Selective Oxidation of Heterocyclic Amines
Award amount
$499,916Program and phase
SBIR · Phase IIAward year
2016Award details
- Awarding agency
- Department of Defense
- Branch
- Army
- Recipient company
- Omm Scientific, Inc
- Proposal award date
- 2016-08-11
- Contract end date
- 2017-08-10
- UEI
- DM23ABHM6JK1
- Solicitation number
- Not reported
- Topic code
- Non-DoD
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Development of a Broad Spectrum Antiviral for Ebola and Marburg viral Infections
- Rapid Feasibility Studies for Novel Routes to Direct CL-20 Intermediates
- TOPIC 323 PHASE I; DEVELOPMENT OF RADIATION MODULATORS FOR USE DURING RADIOTHERAP
- Selective Oxidation of Heterocyclic Amines
- SBIR TOPIC 255, PHASE I: DEVELOPMENT OF ANTICANCER VATPASE INHIBITORS
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- 3D Printed Carbon/Carbon Aeroshell
- Space Edge Experiments and Demonstrations (SEED)
- Biological Activity Assay and Bioanalytical Test Method Development for a Silk-Derived Protein (SDP) Eye Drop Product
- In Situ Production of Biocidal Reactive Oxygen via Directed Energy
- Real-time Volumetric Weather/Propagation Loss Model
Research funding history
9 SBIR/STTR records share this UEI (2007–2016). Reported award amounts total $2,584,560. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Defense